In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 AbbVie 2 Daiichi Sankyo 2

Pricing & policy · first seen yesterday, updated yesterday

Gilead: HIV Growth Is Not Enough At The Current Price

1 outlet Gilead Sciences

Coverage 1 article · 1 outlet

Seeking Alpha Healthcare yesterday
Gilead: HIV Growth Is Not Enough At The Current Price